early

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in the United Kingdom

November 13, 2025 18:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Eisai…

3 months ago

Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…

3 months ago

ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…

3 months ago

Galeries Lafayette to open doors in India with Aditya Birla Group early next month

The debut flagship in Mumbai's Kala Ghoda district will bring global fashion, beauty, and experiential retail to India's luxury market…

3 months ago

AAF Management Closes $55M for Early Stage Hybrid Fund

Washington, D.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Venture capital firm AAF announced today that it has closed a $55M…

4 months ago

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

September 28, 2025 19:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…

4 months ago

LANZAJET – AN EARLY MOVER IN AUSTRALIA – APPLAUDS THE AUSTRALIAN GOVERNMENT’S LEADERSHIP AND GAME-CHANGING $1.1B (AUD) INVESTMENT TO ADVANCE SUSTAINABLE FUELS

LanzaJet's Alcohol-to-Jet technology for sustainable fuel production is key to enabling the development of the industry in Australia while strengthening…

5 months ago

The Aleo Network Foundation Joins Binance Alpha, Expanding Early Access to Privacy-First Blockchain

Binance Alpha Pre-Listing Program Makes the ALEO Token Accessible to Millions of Users Worldwide Within the Binance Ecosystem SAN FRANCISCO,…

5 months ago

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from…

5 months ago

How Sparkvia AI Website Tool Proves Real AI Utility on XRP SPARK Public Sale is Open for Early Investors

VALLETTA, Malta, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sparkvia AI has officially opened the public sale of its utility token,…

5 months ago